THE TYPE II CD20 ANTIBODY GA101 DIFFERS FROM THE TYPE I CD20 ANTIBODY RITUXIMAB IN INDUCING DIFFERENTIAL GENE EXPRESSION PROFILES AND BY BINDING SEPARATE AND FUNCTIONALLY DISTINCT CD20 COMPLEXES ON B CELL LYMPHOMA CELL LINES
ANNALS OF ONCOLOGY（2011）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要